A. Lazaryan

发表

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

M. Horowitz, J. Pidala, Stephanie J. Lee, 2016, Haematologica.

Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, F. Awan, D. Miklos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).

Dae Hyun Lee, Matthew J. Frigault, N. Raje, 2019, Journal of the American College of Cardiology.

Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies

H. Kantarjian, Jeffrey S. Miller, A. Frankel, 2015, Clinical Cancer Research.

Evolving concepts in prognostic scoring of chronic GvHD

M. Arora, A. Lazaryan, M. Arora, 2017, Bone Marrow Transplantation.

Can G-CSF cause leukemia in hematopoietic stem cell donors?

E. Copelan, B. Avalos, A. Lazaryan, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of total body irradiation based myeloablative conditioning regimen in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant: systematic review and meta-analysis.

J. Pidala, A. Mishra, L. Ochoa, 2021, Transplantation and cellular therapy.

Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from BMT CTN 1205 Study

S. Tarima, L. Morris, N. Majhail, 2018 .

Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma.

J. Pinilla-Ibarz, F. Locke, J. Chavez, 2021, Transplantation and cellular therapy.

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma

Jianlin Yuan, K. Dusenbery, V. Bachanova, 2017, International journal of radiation oncology, biology, physics.

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis

M. Pasquini, L. Lekakis, V. Bhatt, 2021, Blood advances.

BEAM Conditioning Is Well Tolerated and Yields Similar Survival in Obese and Non-Obese Patients with Lymphoma: No Requirement for Weight-Based Dose Modifications

V. Bachanova, R. Shanley, C. Brunstein, 2016, Bone Marrow Transplantation.

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma.

Y. Balagurunathan, J. Pinilla-Ibarz, F. Locke, 2020, Blood advances.

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

J. Weiss, Stephanie J. Lee, O. Schueller, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor interferon signaling and suppressive myeloid cells associate with CAR T cell failure in large B cell lymphoma.

John E. Mullinax, R. Gonzalez, Xuefeng Wang, 2021, Blood.

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.

Sonali M. Smith, A. Zelenetz, J. Friedberg, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes.

V. Brown, K. Hsu, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans

L. Gardner, J. Sobel, R. Kaslow, 2009, Journal of Virology.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT

V. Bachanova, J. Froelich, C. Ustun, 2015, Bone Marrow Transplantation.

Radiation Therapy As a Bridging Strategy for Refractory Diffuse Large B Cell Lymphoma Patients Awaiting CAR T Manufacturing of Axicabtagene Ciloleucel

Aaron D. Falchook, T. Robinson, F. Locke, 2018, Blood.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

A. Logan, D. Howard, J. Liesveld, 2021, Blood.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2016 .

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL

F. Locke, J. Chavez, B. Shah, 2022, Blood advances.

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

J. Pinilla-Ibarz, Jongphil Kim, F. Locke, 2020, Haematologica.

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

J. Wagner, D. Weisdorf, M. Arora, 2019, Blood advances.

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

J. Pidala, A. Mishra, Jongphil Kim, 2021, Blood advances.

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Christelle M Colin-Leitzinger, B. Sahaf, A. Mishra, 2022, Blood advances.

ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.

J. Pidala, A. Mishra, J. Lancet, 2021, Transplantation and cellular therapy.

Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).

L. Rybicki, M. Kalaycio, B. Pohlman, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rare T Cell Lymphomas

J. Sweetenham, A. Lazaryan, 2012 .

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2018, Blood advances.

Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

L. Lekakis, N. Ghosh, H. Lazarus, 2019, Journal of Hematology & Oncology.

Change in patients' perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma.

H. Jim, B. Small, R. Jayani, 2022, Transplantation and cellular therapy.

Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel

H. Jim, R. Jayani, J. Pinilla-Ibarz, 2021, Cancer medicine.

Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.

D. Weisdorf, M. Arora, A. Rashidi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations

A. Sohani, V. Nardi, S. Yohe, 2016, Modern Pathology.

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

D. Weisdorf, V. Bachanova, Q. Cao, 2016, Bone Marrow Transplantation.

New is forgotten old: IMiDs against chronic GVHD.

A. Lazaryan, 2021, Blood.

Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.

S. Tarima, M. Horowitz, L. Morris, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2015, Blood.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

J. Pidala, A. Mishra, Jongphil Kim, 2021, Bone Marrow Transplantation.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Jeffrey S. Miller, M. MacMillan, D. Weisdorf, 2018, Haematologica.

Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased infections and delayed CD4+ T-cell but faster B-cell Immune Reconstitution after Posttransplant Cyclophosphamide Compared to Conventional GVHD prophylaxis in Allogeneic Transplantation.

J. Pidala, Junmin Whiting, A. Mishra, 2021, Transplantation and cellular therapy.

Poor Mobilization of CD34+ Stem Cells Predicts Inferior Relapse and Survival Outcomes After Autologous Stem Cell Transplantation for Multiple Myeloma

L. Rybicki, M. Kalaycio, E. Copelan, 2011 .

Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection days

L. Rybicki, M. Kalaycio, B. Hill, 2018, Journal of clinical apheresis.

Expecting a Miracle Harvest after Miracle Growth: Controversies of Granulocyte Colony-Stimulating Factor-Mobilized Matched Sibling Donor Transplantation.

A. Lazaryan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans.

L. Gardner, J. Sobel, R. Kaslow, 2011, Human immunology.

Human Leukocyte Antigen B58 Supertype and Human Immunodeficiency Virus Type 1 Infection in Native Africans

E. Karita, J. Mulenga, S. Allen, 2006, Journal of Virology.

Outcomes of kidney retransplantation in recipients with prior post‐transplant lymphoproliferative disorder

A. Matas, A. Kukla, N. Issa, 2016, Clinical transplantation.

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

Mature results of MM‐011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma

G. Srkalović, M. Kalaycio, J. Zeldis, 2014, American journal of hematology.

Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: a Surveillance, Epidemiology, and End Results analysis.

N. Rubin, M. Hordinsky, D. O’Leary, 2018, Journal of the American Academy of Dermatology.

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Stephanie J. Lee, J. Ryan, O. Schueller, 2018 .

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of CD19-directed Chimeric Antigen Receptor T-cell Therapy for Transformed Non-follicular Lymphoma.

J. Pinilla-Ibarz, F. Locke, J. Chavez, 2023, Transplantation and cellular therapy.

Outcomes of CD19 CAR T cell therapy in patients with gastrointestinal tract involvement of large B cell lymphoma.

F. Locke, J. Chavez, B. Shah, 2021, Transplantation and cellular therapy.

Outcomes of CD19 targeted CAR T-cell Therapy for Patients with Reduced Renal Function Including Dialysis.

F. Locke, J. Chavez, B. Shah, 2022, Transplantation and cellular therapy.

Change in neurocognitive performance among patients with non-Hodgkin's lymphoma in the first year after CAR T-cell therapy.

S. Christy, H. Jim, B. Small, 2022, Transplantation and cellular therapy.

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

S. Bhatia, G. Vercellotti, M. MacMillan, 2021, Blood Cancer Journal.

Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.

K. Dusenbery, G. Vercellotti, Jeffrey S. Miller, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas following Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Xuefeng Wang, T. Robinson, F. Locke, 2021, International journal of radiation oncology, biology, physics.

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

M. Aljurf, R. Gale, L. Lekakis, 2020, Cancer.

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma.

J. Pinilla-Ibarz, F. Locke, J. Chavez, 2020, Blood advances.

CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA

Dae Hyun Lee, F. Locke, B. Shah, 2022, Journal of the American College of Cardiology.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

J Wagner, F. Awan, M. Krem, 2022, Transplantation and cellular therapy.

Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-Versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.

M. Kidd, J. Pidala, A. Mishra, 2022, Transplantation and cellular therapy.

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation.

J. Pidala, A. Mishra, Xuefeng Wang, 2021, Blood advances.

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

J. Wagner, M. MacMillan, D. Weisdorf, 2021, Bone Marrow Transplantation.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

F. Baron, M. Krem, C. Hourigan, 2021, Bone Marrow Transplantation.

Impressive response of CD30‐negative, treatment‐refractory mycosis fungoides to brentuximab vedotin

M. Hordinsky, A. Goyal, A. Lazaryan, 2019, Dermatologic therapy.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

M. Robin, M. MacMillan, D. Weisdorf, 2016, Haematologica.

Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome

R. Mckenna, B. Mcclune, A. Lazaryan, 2018, Leukemia & lymphoma.

Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy

T. Robinson, F. Locke, J. Chavez, 2019, International Journal of Radiation Oncology*Biology*Physics.

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study

Dae Hyun Lee, Abhishek Kumar, F. Locke, 2023, Cardio-Oncology.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients

D. Weisdorf, M. Arora, V. Bachanova, 2014, American journal of hematology.

Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression

J. Goedert, J. Margolick, M. Prins, 2006, AIDS.

Long-term impact on contouring skills achieved by online learning. An ESTRO-FALCON-IAEA study

E. Zubizarreta, Z. Alauddin, H. Mahmood, 2018, International Journal of Radiation Oncology*Biology*Physics.

Increased risk of second primary malignancies in patients with mycosis fungoides: a single center cohort study.

N. Rubin, M. Hordinsky, D. O’Leary, 2020, Journal of the American Academy of Dermatology.

Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia

J. Maciejewski, A. Advani, M. Sekeres, 2010, Cancer.

Natural killer cell alloreactivity predicted by killer cell immunoglobulin-like receptor ligand mismatch does not impact engraftment in umbilical cord blood and haploidentical stem cell transplantation.

V. Brown, V. Bhatt, Stephanie J. Lee, 2022, Transplantation and cellular therapy.

Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-Versus-Host Disease.

J. Pidala, L. Perez, A. Lazaryan, 2023, Transplantation and cellular therapy.

CNS Prophylaxis during Front-Line Therapy in Aggressive Non-Hodgkin Lymphomas: Real-World Outcomes and Practice Patterns from 19 US Academic Institutions

R. Advani, Sonali M. Smith, J. Chavez, 2020 .

ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma

S. Neelapu, O. Oluwole, A. Kilcoyne, 2022, Blood.

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

R. Advani, Sonali M. Smith, J. Chavez, 2021, Blood.

A pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplant recipients using a national registry.

T. Druley, Mingxiang Teng, J. Pidala, 2023, Transplantation and cellular therapy.

Association of high baseline metabolic tumor volume with response following axicabtagene ciloleucel in refractory large B-cell lymphoma.

Y. Balagurunathan, J. Pinilla-Ibarz, F. Locke, 2019, Journal of Clinical Oncology.

Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience.

K. Almhanna, R. Kim, S. Kalmadi, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Real‐world evidence of the safety and survival with CD19 CAR‐T cell therapy for relapsed/refractory solid organ transplant‐related PTLD

A. Evens, C. Jacobson, S. Chowdhury, 2023, British journal of haematology.

Vascular endothelial growth factor receptor 2 (VEGFr2) expression and recurrence of hepatocellular carcinoma following liver transplantation: The Cleveland Clinic experience

Charles M. Miller, J. Fung, F. Aucejo, 2008 .

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

J. Pidala, A. Mishra, Jongphil Kim, 2022 .

B. Sandmaier, M. Aljurf, M. Grunwald, 2019, Haematologica.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.